DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

References

Kruse-Jarres R, Callaghan MU, Croteau SE. , et al.
Surgical experience in two multicenter, open-label phase 3 studies of emicizumab in persons with hemophilia A with inhibitors (HAVEN 1 and HAVEN 2).

Blood 2017;
130 (Suppl. 01) 89

Download Bibliographical Data

Search in: